Are you a healthcare professional seeking clarity on the evolving treatments for sickle cell disease (SCD)?
In this 20-minute episode, experts from cellular therapy and bone marrow transplantation (BMT) explore key updates in SCD care, including curative therapies, gene-editing innovations, and BMT approaches. They address practical challenges in integrating these treatments into practice and discuss strategies to improve access and outcomes. Tune in to discover how collaboration between cellular therapy and BMT providers is transforming care and paving the way for better patient experiences.
Learning Objectives
- Understand recent advancements in curative therapies, including gene editing and BMT, for sickle cell disease.
- Identify key challenges and barriers to integrating new treatments into clinical practice for SCD patients.
- Explore collaborative care strategies between cellular therapy and BMT providers to improve patient outcomes and access.
What is HemeTalks: Conversations in Hematology Education?
HemeTalks: Conversations in Hematology Education is an American Society of Hematology (ASH) podcast for community hematologists, advanced practice providers, and trainees. Through engaging storytelling and case-based discussions with guests ranging from early-career professionals to leading experts, the podcast offers practical strategies that make complex hematology topics accessible and relevant at every career stage. Its mission is to support the educational needs of its audience through high-quality, clinically focused content.